Results 251 to 260 of about 40,750 (280)

Levetiracetam

Reactions Weekly, 2014
  +5 more sources

Levetiracetam

Reactions Weekly, 2021
openaire   +2 more sources

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Lancet, The, 2021
Anthony Guy Marson, Girvan Burnside, David Smith   +2 more
exaly  

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Lancet, The, 2021
Anthony Guy Marson, Girvan Burnside, David Smith   +2 more
exaly  

Levetiracetam

Reactions Weekly, 2003
openaire   +2 more sources

Levetiracetam

Reactions Weekly, 2023
openaire   +2 more sources

Levetiracetam

Reactions Weekly, 2017
openaire   +2 more sources

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial

Lancet, The, 2020
Jaideep Kapur, Shlomo Shinnar, Jordan Elm   +2 more
exaly  

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity

JAMA Neurology, 2021
Kamalini G Ranasinghe, Alexander J Beagle, Lennart Mucke   +2 more
exaly  

Levetiracetam

Reactions Weekly
  +6 more sources